Troy Edward Wilson insider trades

Open-market stock purchases and sales by Troy Edward Wilson, Director at Puma Biotechnology, Inc, from SEC Form 4 filings since Oct 18, 2013.

Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +29%.

Recent trades

DateStockTradeValue
Jun 12, 2026PBYI Puma Biotechnology, IncSold$77.7K
Jun 11, 2026PBYI Puma Biotechnology, IncBought (not open market)—
Mar 23, 2026KURA Kura Oncology, IncBought (not open market)—
Feb 27, 2026RNA Atrium Therapeutics, IncBought (not open market)—
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)—
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)—
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$337K
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$539K
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$391K
Jan 2, 2026KURA Kura Oncology, IncBought (not open market)—
Nov 13, 2025KURA Kura Oncology, IncBought (not open market)—

Companies traded

  • PBYI Puma Biotechnology, Inc: 7 sales, last Jun 12, 2026
  • KURA Kura Oncology, Inc: 3 buys, 20 sales, last Mar 23, 2026
  • RNA Atrium Therapeutics, Inc: 6 sales, last Feb 27, 2026
  • RNAM Avidity Biosciences, Inc: other filings, last Feb 27, 2026
  • ZSAN Zosano Pharma Corp: other filings, last Jan 2, 2019

Get free alerts when Troy Edward Wilson files a new trade →